John Steinberg, DPM
Foot & Ankle Surgery · Washington, DCNPI 1265432009
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Integra Lifesciences Corporation at 55.5% of the total. 2025 is the largest year on record at $95,103, more than ten times the $1,454 reported in 2019. Among foot & ankle surgery clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $630.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$92K
- Solventum Corporation$27K
- Medline Industries LP$24K
- Medshape, Inc.$8K
- Polynovo North America LLC$4K
- Averitas Pharma Inc.$3K
- plus $9K from 28 others
What the payments were for
- Consulting fees$93,81056%
- Speaking & faculty fees$31,11319%
- Travel & lodging$26,02316%
- Food & beverage$6,4014%
- Education$220%
- Other$8,9885%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 114 | $92,334 |
| Solventum Corporation | 16 | $26,682 |
| Medline Industries LP | 14 | $23,578 |
| Medshape, Inc. | 1 | $8,043 |
| Polynovo North America LLC | 7 | $3,668 |
| Averitas Pharma Inc. | 7 | $3,369 |
| ETS Wound Care LLC | 3 | $3,034 |
| Paratek Pharmaceuticals, Inc. | 3 | $1,702 |
| Stryker | 18 | $1,131 |
| Smith+Nephew | 27 | $598 |
| KCI USA, Inc. | 2 | $450 |
| Organogenesis Inc. | 10 | $388 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $175 |
| Osteomed LLC | 2 | $173 |
| Mimedx Group, Inc. | 6 | $141 |
| Hydrofera LLC | 4 | $121 |
| Tactile Systems Technology Inc | 7 | $106 |
| Fusion Orthopedics USA, LLC | 1 | $87 |
| Embody, Inc. | 1 | $87 |
| Reapplix Inc. | 2 | $81 |
| GRT US Holding, Inc. | 3 | $55 |
| Ossio Inc | 1 | $55 |
| Bone Support Inc. | 1 | $44 |
| Polarityte, Inc. | 2 | $43 |
| Davol Inc. | 1 | $36 |
| Johnson & Johnson | 1 | $28 |
| Next Science LLC | 1 | $27 |
| Acera Surgical, Inc. | 1 | $26 |
| Urgo Medical North America, LLC | 1 | $20 |
| Acumed LLC | 1 | $18 |
| Cashflow Solutions, LLC | 1 | $16 |
| OVIK Health, LLC | 1 | $16 |
| Trimed, Inc. | 1 | $13 |
| Terumo Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$180,941
- Dermatology and Wound Care$19,536
- V.A.C. VERAFLO$17,718
- V.A.C. DERMATAC$16,931
- PREVENA$16,054
- Bair Hugger$13,781
- 3M Cavilon$13,781
- ACTIV.A.C.$9,450
- PRIMATRIX$7,367
- INTEGRA DERMAL REGENERATION TEMPLATE$5,531
- Novosorb BTM$3,547
- Qutenza$3,220
- V.A.C. VERAFLO CLEANSE CHOICE$3,150
- MIRRAGEN ADVANCED WOUND MATRIX$3,000
- KERRALITE COOL (NON ADHESIVE)$2,100
- PREVENA RESTOR AXIOFORM$1,838
- PREVENA RESTOR BELLAFORM$1,838
- AMNIOEXCEL$1,700
- NUZYRA$1,680
- KERRACEL AG$1,575
How this compares
$166,357 in reported general payments places this provider in the 95th percentile of 23 foot & ankle surgery providers in District of Columbia.
See all foot & ankle surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 17 | $957 |
| Diclofenac Sodium | 34 | $949 |
| Pregabalin | 34 | $705 |
| Ammonium Lactate | 22 | $643 |
| Terbinafine Hcl | 50 | $480 |
| Ciclopirox | 11 | $342 |
| Doxycycline Hyclate | 29 | $252 |
| Clotrimazole | 11 | $138 |
| Gabapentin | 13 | $87 |
| Oxycodone Hcl | 18 | $82 |
| Meloxicam | 50 | $79 |
| Tramadol Hcl | 16 | $36 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Washington
- Paul CooperWashington$186K
- Ali Rahnama VaghefWashington$132K
- Jayson AtvesWashington$24K
- Shelton McKenzieWashington$22K
- Bilal LouzatiWashington$18K
- Ali QadriWashington$17K
- Alex MattiaWashington$13K
- Emily DurranceWashington$9K
- Selin RuggieriWashington$7K
- Caitlin ZarickWashington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.